PRE PRENETICS GLOBAL LIMITED

Prenetics Announces Participation in December Investor Conferences

Prenetics Announces Participation in December Investor Conferences

CHARLOTTE, N.C., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited, (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced that members of the Prenetics management team will participate in two upcoming investor conferences.

iAccess Alpha Virtual Best Ideas Winter Conference 2024

Date: December 10-11, 2024

Location: Virtual

Presentation: December 10, 2024 at 10:00am ET

Webcast:

Danny Yeung, Chief Executive Officer, will deliver a presentation on December 10, 2024, and will be joined by Stephen Lo, Chief Financial Officer, and David Vanderveen, President of Prenetics Americas, for one-on-one investor meetings to be held on December 11, 2024.

13th Annual ROTH Deer Valley Event

Date: December 11-13, 2024

Location: Park City, UT

David Vanderveen, President of Prenetics Americas, will be hosting one-on-one investor meetings throughout the conference.

Mr. Vanderveen has had a successful 30-year track record in beverage, nutrition, and technology, leading disruptive change at both Nirvana Water Sciences and XS Worldwide as prior CEO.

For more information or to schedule a meeting with management, please contact the Company’s investor relations at .

About Prenetics

Prenetics (NASDAQ:PRE), a leading health sciences company, is dedicated to advancing consumer and clinical health. Our consumer initiative is led by IM8, a new health and wellness brand and Europa, one of the largest sports distribution companies in the USA. Our clinical division is led by Insighta, our $200 million venture focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for comprehensive genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer comprehensive DNA tests. Each of Prenetics’ units synergistically enhances our global impact on health, embodying our commitment to ‘enhancing life through science’. To learn more about Prenetics, please visit .

Investor Relations Contact:



Angela Cheung

Investor Relations / Corporate Finance

Prenetics Global Limited



EN
04/12/2024

Underlying

PREPRENETICS GLOBAL LIMITED

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PRENETICS GLOBAL LIMITED

 PRESS RELEASE
Free
PRE PRENETICS GLOBA...

IM8 Vibrante Miami: Fueling Wellness and Innovation with a Star-Studde...

IM8 Vibrante Miami: Fueling Wellness and Innovation with a Star-Studded Event David Beckham was Joined by Dr. Amy Shah, Dr. Jeremy London, Dr. James DiNicolantonio and Kendal Toole to Reinforce IM8’s Vision for Elite Wellness Accessible to All CHARLOTTE, N.C., April 09, 2025 (GLOBE NEWSWIRE) -- On Monday, , the premium supplement brand co-founded by , hosted IM8 Vibrante - A Celebration of Science, Wellness & Flavor, a memorable evening at the iconic on Miami Beach. In attendance were nearly 150 wellness influencers, creators, science and medical advisors, and media members to celebrate...

April 9, 2025 1 EN
 PRESS RELEASE
Free
PRE PRENETICS GLOBA...

Prenetics’ IM8 Health Expands Scientific Advisory Board, Reinforcing C...

Prenetics’ IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market Adds Renowned Clinical Experts Dr. Jeremy London and Dr. Amy Shah to Existing Team from Mayo Clinic, Cedars-Sinai, NASA and Yale University CHARLOTTE, N.C., March 18, 2025 (GLOBE NEWSWIRE) --  , the premium supplements brand co-founded by David Beckham, today announced the addition of two distinguished new members, Dr. Jeremy London and Dr. Amy Shah, to its world-class (SAB). These additions underscore IM8’s unwavering commitment to leading innovation in science, lo...

March 18, 2025 1 EN
 PRESS RELEASE
Free
PRE PRENETICS GLOBA...

Prenetics to Participate in the 37th Annual ROTH Conference

Prenetics to Participate in the 37th Annual ROTH Conference CHARLOTTE, N.C., March 11, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading consumer health sciences company, announced today the Company will participate in the 37th Annual ROTH Conference being held Sunday, March 16th to Tuesday, March 18th at the Laguna Cliffs Marriott Resort in Dana Point, CA. Prenetics’ Chief Executive Officer Danny Yeung and President of Americas David Vanderveen will be available to host one-on-one meetings with investors during the event. In addition, management will participate...

March 11, 2025 1 EN
 PRESS RELEASE
Free
PRE PRENETICS GLOBA...

Prenetics Announces Fourth Quarter and Full Year 2024 Financial Result...

Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance Revenue grew 93.5% to $10.5 million in the fourth quarter and 40.9% year-over-year to $30.6 million in 2024 Cash and short-term assets of $84.8 million as of December 31, 2024 Provides first quarter and full year 2025 guidance Projects full year 2025 revenue of $73 million to $85 million, driven by the strong launch of CHARLOTTE, N.C., March 05, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences ...

March 5, 2025 1 EN
 PRESS RELEASE
Free
PRE PRENETICS GLOBA...

Nasdaq-Listed Prenetics Announces Genomics-Based Partnership with Huma...

Nasdaq-Listed Prenetics Announces Genomics-Based Partnership with Humanity Protocol and Launches Crypto Strategic Reserve CircleDNA powers blockchain-based identity verification with Humanity Protocol, valued at US $1.1bn after latest fundraisePrenetics invests $1.5M in Bitcoin, Solana and H tokens, supported by strong balance sheetPrenetics advances Decentralized Science (DeSci) with AI-driven early cancer detection, backed by $30M investment from Tencent CHARLOTTE, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading genomics and consumer healthcare...

February 11, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch